Bright Health Group

Bright Health Group, Inc. engages in the provision of healthcare products and services for consumers and care providers in local markets. It offers individual and family, and Medicare Advantage health plans. It operates through the Bright HealthCare and NeueHealth segments. The Bright HealthCare segment offers commercial and Medicare health plan products. The NeueHealth segment provides care delivery and value-based enablement services. The company was founded by Robert J. Sheehy, Tomas Valdivia, and Kyle Rolfing in 2015 and is headquartered in Minneapolis, MN.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q3 2024

Bright Health Group targets EBITDA profitability in 2023 amid challenges

Bright Health Group (BHG) aims for adjusted EBITDA profitability in 2023, focusing on value-driven care and consumer growth across segments.
Challenges from discontinued operations and the need for additional capital highlight the importance of financial management and operational efficiency.
Strong liquidity position and strategic actions to improve operating expenses position BHG for sustained growth and profitability in the healthcare insurance market.
Management's strategic planning and focus on comparable performance in 2023 demonstrate a commitment to financial stability and operational excellence.

Bright Health Group reports strong Q1 performance and strategic shifts

Bright Health Group's Q1 2023 performance reflects financial stability and growth potential in key segments.
Operational strengths in Consumer Care and prudent risk management position the company for sustainable success.
Challenges in transitioning Medicare Advantage business and achieving profitability require strategic focus.
Strategic opportunities in portfolio optimization and revenue growth pave the way for future success.

Bright Health Group posts strong Q2 earnings, eyes sustained growth

Bright Health Group's Q2 2023 earnings call highlighted robust financial results, strategic initiatives to drive growth, and a focus on long-term sustainability. The company's positive operating income, revenue growth, and adjusted EBITDA signify operational strength and progress towards profitability. While facing challenges in a competitive market, Bright Health Group is well-positioned to leverage opportunities in value-driven care and partnerships for future expansion.

Bright Health Group reports strong Q3 performance and strategic divestiture

Bright Health Group's Q3 2023 performance reflects resilience, strategic planning, and a commitment to quality healthcare services amidst industry challenges.
Despite facing headwinds like the wind down of ACA insurance business and external impacts, the company maintains a strong financial position and focuses on profitability.
Strategic divestitures, operational improvements, and a clear outlook for growth underscore Bright Health Group's potential for sustainable success in the healthcare sector.
With a focus on innovation, value-based care, and financial discipline, Bright Health Group navigates challenges to seize opportunities for future growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

NeueHealth, Inc. engages in the provision of healthcare products and services for consumers and care providers in local markets. It offers individual and family, and Medicare Advantage health plans. It operates through the Bright HealthCare and NeueHealth segments. The Bright HealthCare segment offers commercial and Medicare health plan products. The NeueHealth segment provides care delivery and value-based enablement services. The company was founded by Robert J. Sheehy, Tomas Valdivia, and Kyle Rolfing in 2015 and is headquartered in Doral, FL.

MINNEAPOLIS--(BUSINESS WIRE)--Bright Health Group, Inc. ("Bright Health") (NYSE: BHG), the technology enabled, value-driven healthcare company serving aging and underserved consumers with unmet clinical needs, today announced it will report First Quarter financial results before the financial markets open on Tuesday, May 9, 2023, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-register at this link. Upon registration, telephone participants will r.

Bright Health Group to Host First Quarter 2023 Earnings Conference Call on May 9, 2023

Bright Health Group, Inc. (NYSE:BHG ) Q4 2022 Earnings Conference Call March 1, 2023 8:00 AM ET Company Participants Stephen Hagan - Investor Relations Director Mike Mikan - President and Chief Executive Officer Cathy Smith - Chief Financial Officer and Chief Administrative Officer Conference Call Participants Joshua Raskin - Nephron Research Ben Rossi - Citigroup Kevin Fischbeck - Bank of America Justin Lake - Wolfe Research Nathan Rich - Goldman Sachs Operator Hello, and welcome to the Bright Health Group Fourth Quarter 2022 Earnings Call. My name is Alex, and I'll be coordinating the call today.

Bright Health Group, Inc. (BHG) Q4 2022 Earnings Call Transcript

Bright Health (BHG) delivered earnings and revenue surprises of 37.04% and 67.90%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Bright Health Group (BHG) Reports Q4 Loss, Lags Revenue Estimates

MINNEAPOLIS--(BUSINESS WIRE)--Bright Health Group, Inc. (“Bright Health” or the “Company”) (NYSE: BHG), the technology enabled, value-driven healthcare company serving aging and underserved consumers with unmet clinical needs, today reported financial results for its fourth quarter and full year ended December 31, 2022.

Bright Health Group Reports Fourth Quarter and Full Year 2022 Results

Philadelphia, Pennsylvania--(Newsfile Corp. - February 11, 2023) - Kaskela Law LLC announces that it is investigating Bright Health Group, Inc. (NYSE: BHG) on behalf of the company's long-term investors.Bright Health is an integrated care delivery company that engages in the delivery and financing of health insurance plans in the Unites States.

SHAREHOLDER ALERT: Kaskela Law LLC Announces Stockholder Investigation of Bright Health Group, Inc. (BHG) and Encourages Long-Term BHG Investors to Contact the Firm

MINNEAPOLIS--(BUSINESS WIRE)--Bright Health Group, Inc. ("Bright Health") (NYSE: BHG), the technology enabled, value-driven healthcare company serving aging and underserved consumers with unmet clinical needs, today announced it will report Fourth Quarter financial results before the financial markets open on Wednesday, March 1, 2023, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-register at this link.

Bright Health Group to Host Fourth Quarter 2022 Earnings Conference Call on March 1, 2023

The healthcare system in the United States is too disjointed and needs to be integrated. BHG adopts a strategic approach to address the challenges faced by the industry.

Bright Health Group: Stock Price Has Been Too Heavily Beaten Down

MINNEAPOLIS--( BUSINESS WIRE )--Bright Health Group, Inc. ("Bright Health") (NYSE: BHG), a technology enabled, value-driven healthcare company serving aging and underserved consumers, today announced updated 2023 guidance, reinforcing its expectation for Adjusted EBITDA profitability for 2023. In addition, Bright Health has entered 2023 with a strengthened capital position to support its growth plans.

Bright Health Group Announces Updated 2023 Expectations Ahead of J.P. Morgan Healthcare Conference Presentation

Bright Health (BHG) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Bright Health (BHG) Upgraded to Buy: Here's What You Should Know

MINNEAPOLIS--( BUSINESS WIRE )--Bright Health Group, Inc. ("Bright Health") (NYSE: BHG), the technology enabled, value-driven healthcare company serving aging and underserved consumers with unmet clinical needs, today announced Mike Mikan, CEO and President, will present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023, in San Francisco, CA.

Bright Health Group to Present at 41st Annual J.P. Morgan Healthcare Conference

MINNEAPOLIS--( BUSINESS WIRE )--Bright Health Group, Inc. (“Bright Health Group” or the “Company”) (NYSE: BHG), today announced that on December 6, 2022, the Company received a written notice from the New York Stock Exchange (the “NYSE”) that it was not in compliance with the continued listing standard set forth in Section 802.01C of the NYSE's Listed Company Manual, as the average closing price of the Company's common stock was less than $1.00 per share over a consecutive 30 trading-day period ending December 2, 2022. During the cure period, the Company's common stock will continue to trade on the NYSE, subject to the Company's compliance with the NYSE's other continued listing requirements. The notice does not affect the Company's ongoing business operations or its U.S. Securities and Exchange Commission reporting requirements, nor does it cause an event of default under any of the Company's debt obligations.

Bright Health Group Receives Continued Listing Standard Notice from NYSE

MINNEAPOLIS--( BUSINESS WIRE )--Original press release issued November 9, 2022 has been replaced with this version to correct a typographical error in the Financial Outlook section. “Adjusted EBITDA for 2022 is expected to be a loss of between $550.0 million and $700.0 million”, a correction from the original version which listed a range of $500.0 million to $700.0 million.

CORRECTING and REPLACING Bright Health Group Reports Third Quarter 2022 Results

CHICAGO , Nov. 9, 2022 /PRNewswire/ -- NeueHealth Partners Community ACO, a partnership between NeueHealth and Medical Home Network, has been provisionally accepted to participate in the ACO REACH model starting January 1, 2023. The NeueHealth Partners Community ACO expands on two NeueHealth owned and managed Direct Contracting Entities (DCEs) that are transitioning to the ACO REACH model next year, which served approximately 47,000 Medicare beneficiaries as of the Second Quarter 2022.

NeueHealth and Medical Home Network Partner to Reduce Health Care Disparities through New ACO REACH Model

Bright Health Group, Inc. (NYSE:BHG ) Q3 2022 Earnings Conference Call November 9, 2022 8:00 AM ET Company Participants Stephen Hagan - Director, IR Mike Mikan - President & CEO Cathy Smith - CFO & CAO Conference Call Participants Nathan Rich - Goldman Sachs Joshua Raskin - Nephron Research Steven Valiquette - Barclays Lisa Gill - J.P. Morgan Chase Michael Hall - Morgan Stanley Kevin Fischbeck - Bank of America Gary Taylor - Cowen Operator Hello and welcome to today's Bright Health Group Third Quarter 2022 Earnings Call.

Bright Health Group, Inc. (BHG) CEO Mike Mikan on Q3 2022 Results - Earnings Call Transcript

Bright Health (BHG) delivered earnings and revenue surprises of 12.50% and 8.52%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Bright Health Group (BHG) Reports Q3 Loss, Misses Revenue Estimates

MINNEAPOLIS--(BUSINESS WIRE)--Bright Health Group, Inc. (“Bright Health Group” or the “Company”) (NYSE: BHG), the technology enabled, value-driven healthcare company serving aging and underserved consumers with unmet clinical needs, today reported financial results for its third quarter ended September 30, 2022.

Bright Health Group Reports Third Quarter 2022 Results

MINNEAPOLIS--(BUSINESS WIRE)--Bright Health Group, Inc. ("Bright Health") (NYSE: BHG) today announced it will report Third Quarter financial results before the financial markets open on Wednesday, November 9, 2022, followed by a conference call at 8:00 AM Eastern Time.

Bright Health Group to Host Third Quarter 2022 Earnings Conference Call on November 9, 2022

MINNEAPOLIS--(BUSINESS WIRE)--Bright Health Group (NYSE: BHG) closes offering of Series B convertible perpetual preferred stock for $175M in aggregate proceeds.

Bright Health Group Announces Closing of $175 Million Capital Raise to Support Focused Business

MINNEAPOLIS--(BUSINESS WIRE)--Bright Health Group, Inc. (“Bright Health”) (NYSE: BHG) announces focus on its Fully Aligned Care Model, as well as $175M capital raise.

Bright Health Group to Further Focus on Delivering Affordable Healthcare to Aging and Underserved Populations Through Its Fully Aligned Care Model in Florida, Texas, and California

Bright Health Group, Inc. (NYSE:BHG ) Q2 2022 Earnings Conference Call August 10, 2022 8:00 AM ET Company Participants Stephen Hagan - Director, IR Mike Mikan - President & CEO Cathy Smith - CFO & CAO Conference Call Participants Lisa Gill - J.P. Morgan Steven Valiquette - Barclays Nathan Rich - Goldman Sachs Joshua Raskin - Nephron Research Jeff Garro - Piper Sandler Michael Hall - Morgan Stanley Jason Cassorla - Citi Justin Lake - Wolfe Research Kevin Fischbeck - Bank of America Ben Hendrix - RBC Capital Markets Operator Good morning or good afternoon and welcome to the Bright Health Group Q2 2022 Earnings Call.

Bright Health Group's (BHG) CEO Mike Mikan on Q2 2022 Results - Earnings Call Transcript

Bright Health (BHG) delivered earnings and revenue surprises of -18.42% and 14.20%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Bright Health Group (BHG) Reports Q2 Loss, Misses Revenue Estimates

MINNEAPOLIS--(BUSINESS WIRE)--Bright Health Group, technology-enabled, fully-aligned system of healthcare for consumer retail market, reports 2022 second quarter financial results.

Bright Health Group Reports Second Quarter 2022 Results

MINNEAPOLIS--(BUSINESS WIRE)--Bright Health Group, Inc. announced it will report Second Quarter financial results before the financial markets open on Wednesday, August 10, 2022.

Bright Health Group to Host Second Quarter 2022 Earnings Conference Call on August 10, 2022

Wilmington, Delaware--(Newsfile Corp. - June 27, 2022) - Rigrodsky Law, P.A. is investigating potential claims against the officers and directors of Bright Health Group, Inc. (NYSE: BHG) on behalf of stockholders.To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-bright-health-group-inc.To contact Seth D. Rigrodsky or Gina M. Serra cost free, call or text (302) 295-5310 or email info@rl-legal.com.Rigrodsky Law, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars...

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Bright Health Group, Inc.

MINNEAPOLIS--(BUSINESS WIRE)--Bright Health Group, Inc. ("Bright Health") (NYSE: BHG), the first technology-enabled, Fully Aligned System of Care built for healthcare's consumer retail market, today announced the expansion of its leadership team with the addition of Michael Carson as Bright HealthCare Chief Executive Officer and Jeff Cook as NeueHealth Chief Executive Officer. These proven leaders, reporting directly to Bright Health Group CEO Mike Mikan, will focus on leading the Company's two

News for Bright Health Group Stock (BHG)